KYV101
CCM-RNT-202401
Phase 2 small_molecule active
Quick answer
KYV101 for Rheumatoid Arthritis is a Phase 2 program (small_molecule) at Kyverna Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kyverna Therapeutics
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active